The estimated Net Worth of Christopher J. Calamari is at least $3.08 Milione dollars as of 28 February 2022. Christopher Calamari owns over 706 units of Abbott Laboratories stock worth over $2,991,723 and over the last 3 years Christopher sold ABT stock worth over $83,414.
Christopher has made over 1 trades of the Abbott Laboratories stock since 2022, according to the Form 4 filled with the SEC. Most recently Christopher sold 706 units of ABT stock worth $83,414 on 28 February 2022.
The largest trade Christopher's ever made was selling 706 units of Abbott Laboratories stock on 28 February 2022 worth over $83,414. On average, Christopher trades about 118 units every 0 days since 2021. As of 28 February 2022 Christopher still owns at least 25,658 units of Abbott Laboratories stock.
You can see the complete history of Christopher Calamari stock trades at the bottom of the page.
Christopher's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez e Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: